BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21171232)

  • 21. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
    Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
    Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective and comparative analysis of (99m)Tc-Sestamibi breast specific gamma imaging versus mammography, ultrasound, and magnetic resonance imaging for the detection of breast cancer in Chinese women.
    Yu X; Hu G; Zhang Z; Qiu F; Shao X; Wang X; Zhan H; Chen Y; Deng Y; Huang J
    BMC Cancer; 2016 Jul; 16():450. PubMed ID: 27401536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast cancer stage at diagnosis and geographic access to mammography screening (New Hampshire, 1998-2004).
    Celaya MO; Berke EM; Onega TL; Gui J; Riddle BL; Cherala SS; Rees JR
    Rural Remote Health; 2010; 10(2):1361. PubMed ID: 20438282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer stage at diagnosis: is travel time important?
    Henry KA; Boscoe FP; Johnson CJ; Goldberg DW; Sherman R; Cockburn M
    J Community Health; 2011 Dec; 36(6):933-42. PubMed ID: 21461957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating wait times from screening to breast cancer diagnosis among women undergoing organised assessment vs usual care.
    Chiarelli AM; Muradali D; Blackmore KM; Smith CR; Mirea L; Majpruz V; O'Malley FP; Quan ML; Holloway CM
    Br J Cancer; 2017 May; 116(10):1254-1263. PubMed ID: 28359079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health Reform, Medicaid Expansions, and Women's Cancer Screening.
    Ku L; Bysshe T; Steinmetz E; Bruen BK
    Womens Health Issues; 2016; 26(3):256-61. PubMed ID: 26926159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delay in diagnostic testing after abnormal mammography in low-income women.
    Wujcik D; Shyr Y; Li M; Clayton MF; Ellington L; Menon U; Mooney K
    Oncol Nurs Forum; 2009 Nov; 36(6):709-15. PubMed ID: 19887359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The joint effects of census tract poverty and geographic access on late-stage breast cancer diagnosis in 10 US States.
    Henry KA; Sherman R; Farber S; Cockburn M; Goldberg DW; Stroup AM
    Health Place; 2013 May; 21():110-21. PubMed ID: 23454732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nation-wide data on screening performance during the transition to digital mammography: observations in 6 million screens.
    van Luijt PA; Fracheboud J; Heijnsdijk EA; den Heeten GJ; de Koning HJ;
    Eur J Cancer; 2013 Nov; 49(16):3517-25. PubMed ID: 23871248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential impact of USPSTF recommendations on early diagnosis of breast cancer.
    Aragon R; Morgan J; Wong JH; Lum S
    Ann Surg Oncol; 2011 Oct; 18(11):3137-42. PubMed ID: 21947591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of breast cancer cases according to county-level poverty status in 3.5 million rural women who participated in a breast cancer screening program of Hunan province, China from 2016 to 2018.
    Lili X; Zhiyu L; Yinglan W; Aihua W; Hongyun L; Ting L; Yingxia W; Guanghui Y; Xianghua C; Junqun F; Donghua X; Fanjuan K
    Medicine (Baltimore); 2020 Apr; 99(17):e19954. PubMed ID: 32332679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of a short-term imaging follow-up after a benign result in a one-stop breast unit: Is it still useful?
    Daroles J; Borget I; Suciu V; Mazouni C; Delaloge S; Balleyguier C
    Eur J Cancer; 2017 Nov; 85():23-30. PubMed ID: 28881248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Dana-Farber CISNET Model for Breast Cancer Screening Strategies: An Update.
    Lee SJ; Li X; Huang H; Zelen M
    Med Decis Making; 2018 Apr; 38(1_suppl):44S-53S. PubMed ID: 29554465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast MRI screening for average-risk women: A monte carlo simulation cost-benefit analysis.
    Mango VL; Goel A; Mema E; Kwak E; Ha R
    J Magn Reson Imaging; 2019 Jun; 49(7):e216-e221. PubMed ID: 30632645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventive care: female cancer screening, 1996-2000.
    Adams EK; Florence CS; Thorpe KE; Becker ER; Joski PJ
    Am J Prev Med; 2003 Nov; 25(4):301-7. PubMed ID: 14580631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A culturally targeted intervention to promote breast cancer screening among low-income women in East Baltimore, Maryland.
    Garza MA; Luan J; Blinka M; Farabee-Lewis RI; Neuhaus CE; Zabora JR; Ford JG
    Cancer Control; 2005 Nov; 12 Suppl 2():34-41. PubMed ID: 16327749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early-stage breast cancer treatment among medically underserved women diagnosed in a national screening program, 1992-1995.
    Richardson LC; Schulman J; Sever LE; Lee NC; Coate RJ
    Breast Cancer Res Treat; 2001 Sep; 69(2):133-42. PubMed ID: 11759819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Timely care after an abnormal mammogram among low-income women in a public breast cancer screening program.
    Lobb R; Allen JD; Emmons KM; Ayanian JZ
    Arch Intern Med; 2010 Mar; 170(6):521-8. PubMed ID: 20233801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved detection rate of early breast cancer in mass screening combined with mammography.
    Ohuchi N; Yoshida K; Kimura M; Ouchi A; Kamioki S; Shiiba K; Matoba N; Kojima S; Takahashi K; Matsuno S
    Jpn J Cancer Res; 1993 Jul; 84(7):807-12. PubMed ID: 8396569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.